Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

8.9%

14 terminated/withdrawn out of 157 trials

Success Rate

83.7%

-2.8% vs industry average

Late-Stage Pipeline

4%

7 trials in Phase 3/4

Results Transparency

14%

10 of 72 completed trials have results

Key Signals

44 recruiting10 with results13 terminated

Enrollment Performance

Analytics

N/A
84(64.1%)
Phase 2
26(19.8%)
Phase 1
14(10.7%)
Phase 3
7(5.3%)
131Total
N/A(84)
Phase 2(26)
Phase 1(14)
Phase 3(7)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (157)

Showing 20 of 157 trials
NCT06834685Not ApplicableRecruiting

Evaluating Laser Photobiomodulation for the Treatment of Neuropathic Pain in Chemotherapy-induced Peripheral Neuropathy in Cancer Patients

Role: lead

NCT05109468Active Not Recruiting

Assessment of Patients' Quality of Sexual Life After Anal Cancer Treatment

Role: lead

NCT07717450Phase 3Not Yet Recruiting

Rising ctDNA to Tailor Endocrine Therapy Switch in Patients With ER+/HER2- Metastatic Breast Cancer.

Role: collaborator

NCT04414202Active Not Recruiting

Observational Study of Intra-operative Partial Irradiation of Invasive Ductal Breast Carcinomas With a Good Prognosis

Role: lead

NCT04456920Not ApplicableCompleted

Pain Monitoring After Breast Biopsy: Benefit of E-health

Role: lead

NCT03254420Not ApplicableActive Not Recruiting

Evaluation of Late Toxicity Following Intensity-Modulated Radiotherapy and Two Image-Guided Strategies With Corresponding Treatment Margins.

Role: lead

NCT04770090Not ApplicableActive Not Recruiting

Research of Circulating Tumor Cells Released During Cervical Cancer Surgery

Role: collaborator

NCT05025514Terminated

Retrospective Study of COVID-19 Vaccines in Patients Undergoing Immunotherapy for Cancer.

Role: collaborator

NCT06147960Recruiting

Prognostic Role of Inhibitor of Apoptosis Protein Overexpression on Recurrence Rate in Cervical Cancer

Role: collaborator

NCT07645950Not Yet Recruiting

Effect of the MIROKI Companion Robot on Anxiety in Pediatric Radiotherapy

Role: lead

NCT06575452Not ApplicableRecruiting

Using the Epitranscriptome to Diagnose and Treat Gliomas

Role: lead

NCT04954820Phase 2Recruiting

Assessment of Retreatment With Lutathera® in Patients With New Progression of Intestinal Well-differenciated NET

Role: lead

NCT04285476Not ApplicableActive Not Recruiting

Predictive Value of microRNA in Thyroid Cytologies of Undetermined Type

Role: lead

NCT04457895Not ApplicableRecruiting

Evaluation of the Efficacy of a Physical Therapy-yoga-patient Educational Program for Breast Cancer Patients With Pain Due to Hormonal Therapy Treatment.

Role: lead

NCT06263283Not ApplicableActive Not Recruiting

Impact of an Educational Physiotherapy-Yoga Intervention on Perceived Stress in Women Treated With Brachytherapy for Cervical Cancer

Role: lead

NCT07404228Not Yet Recruiting

Multidimensional Study Designed to Develop a Methodological Framework Based on MRI Data to Predict Pathological Complete Response (pCR) in Patients With Locally Advanced Rectal Cancer After Neoadjuvant Treatment

Role: lead

NCT07418060Not ApplicableNot Yet Recruiting

Evaluation of the Impact of Pre-habilitation Using Physiotherapy and Mechanical Stimulation on Shoulder Pain and Mobility in Patients Undergoing Breast Reconstruction Using a Latissimus Dorsi Flap

Role: lead

NCT03975959Not ApplicableCompleted

Memory Perception Assessment in Central/Non-central Nervous System Cancers

Role: lead

NCT07098182Not ApplicableRecruiting

Contribution of Preserving the Superior Left Colic Artery to the Vascularization of the Descending Colon Prior to Colorectal Anastomosis During Left-Sided or Rectal Resections for Colorectal or Ovarian Cancer. (Revascularisation Colique)

Role: lead

NCT04104529Not ApplicableRecruiting

Clinico-biological Database in Patients Treated With Metabolic Radiotherapy in the Nuclear Medicine Department

Role: lead